ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹50,298 Cr | ₹34,858 Cr | ₹27,637 Cr | ₹24,494 Cr | ₹26,700 Cr |
What is the latest Total Liabilities ratio of ZYDUS LIFESCIENCES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹50,298 Cr |
| Mar2025 | ₹34,858 Cr |
| Mar2024 | ₹27,637 Cr |
| Mar2023 | ₹24,494 Cr |
| Mar2022 | ₹26,700 Cr |
How is Total Liabilities of ZYDUS LIFESCIENCES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹50,298 Cr | 44.29 | |
| Mar2025 | ₹34,858 Cr | 26.13 | |
| Mar2024 | ₹27,637 Cr | 12.83 | |
| Mar2023 | ₹24,494 Cr | -8.26 | |
| Mar2022 | ₹26,700 Cr | - | |
Compare Total Liabilities of peers of ZYDUS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZYDUS LIFESCIENCES | ₹112,717.5 Cr | 2.3% | 2% | 11.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,952.0 Cr | 1% | -2.9% | 17.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹230,427.0 Cr | 1.8% | 17% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,141.0 Cr | -1.9% | -1.9% | 33.2% | Stock Analytics | |
| CIPLA | ₹114,715.0 Cr | 0.3% | 0.7% | -7.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,409.9 Cr | 1.7% | 3.5% | -4.1% | Stock Analytics | |
ZYDUS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZYDUS LIFESCIENCES | 2.3% |
2% |
11.3% |
| SENSEX | 0.5% |
2.1% |
-4.5% |
You may also like the below Video Courses